Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
When Anthropic's interpretability team asked whether there might be concepts inside Claude that the model was actively entertaining without writing down, they built a mathematical tool to find out.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results